Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Maryam Fouladi, MD Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry The Cure Starts Now Foundation DIPG - Fouladi 01/01/2012 - 12/31/2018 $233,311
Maryam Fouladi, MD Pediatric Brain Tumor Consortium (PBTC) National Institutes of Health (St Jude's Children's Hospital) UM1 CA081457 04/01/2014 - 03/31/2019 $92,745
Maryam Fouladi, MD Pediatric Brain Tumor Consortium (PBTC) National Institutes of Health (St Jude's Children's Hospital) UM1 CA081457 04/01/2014 - 03/31/2019 $39,000
Brian D Weiss, MD COG NCTN Network Group Operations Center National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 04/11/2014 - 02/28/2019 $23,108
Maryam Fouladi, MD COG NCTN Network Group Operations Center National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 04/11/2014 - 02/28/2019 $7,500
Adrienne Hammill, MD Brain Vascular Malformation Consortium: Predictors of Clinical Course National Institutes of Health (The Regents of the Univ of California) U54 NS065705 09/30/2014 - 07/31/2019 $4,212
John P Perentesis, MD COG NCORP Research Base: Per case Reimbursement National Institutes of Health (Children's Hospital of Philadelphia) UG1 CA189955 08/01/2014 - 07/31/2018 $50,000
Susanne Wells, PhD Targeting Lipid Metabolism in FA for the Prevention and Treatment of Squamous Cell Carcinoma. Fanconi Anemia Research Fund Wells, Sue, FARF 03/01/2016 - 02/28/2018 $125,000
Sonya Ruiz-Torres Role of the Fanconi Anemia DNA Repair Pathway in Epidermal Stem and Progenitor Cells and Squamous Cell Carcinoma National Institutes of Health F31 AR070008 09/01/2016 - 08/31/2019 $37,176
Erin Haag Breese, MD, PhD Total Therapy for Infants with Acute Lymphoblastic Leukemia (ALL) “TINI” St Jude's Children's Hospital TINI 03/01/2016 - 02/29/2020 $31,001
Brian D Weiss, MD A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; HYD SULFATE) in Children with Neurofibromatosis Type I (NF1) and Inoperable Plexiform Neurofibromas (PN) Johns Hopkins School of Medicine 2002883540 01/01/2016 - 12/31/2018 $123,071
Brian D Weiss, MD A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; HYD SULFATE) in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) Johns Hopkins School of Medicine 2001824052 01/01/2016 - 12/31/2018 $137,500
Biplab DasGupta, PhD Biguanide Sensitivity of Glioma Stem Cells National Institutes of Health R01 NS099162 02/01/2016 - 11/30/2021 $347,942
Christine L Phillips, MD Pembrolizumab in Combination with Decitabine in Relapsed/Refractory Pediatric Myeloid Leukemia Cancer Free Kids Phillips, Christine, 07/01/2016 - 06/30/2018 $25,000
Benjamin Mizukawa, MD The Lesser of Two Evils: Weakening Infant Leukemia Through Forced Lineage Switch Cancer Free Kids 50000 07/01/2016 - 06/30/2018 $50,000
Benjamin Mizukawa, MD Precision Medicine in a Pediatric Leukemia Avatar System St. Baldrick's Foundation CDA 07/01/2016 - 06/30/2018 $115,000
Elizabeth A Gilger, APRN, CNP Prospective Symptom Assessment in Children with Advanced Cancer Alex's Lemonade Stand Foundation (University of Wisconsin-Madison) gilger, beth, als 01/15/2016 - 01/14/2018 $9,998
Biplab DasGupta, PhD Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase National Institutes of Health R01 NS072591 07/01/2016 - 06/30/2017 $334,688
Susanne Wells, PhD Role and Regulaton of the Human DEK Proto-Oncogene National Institutes of Health R01 CA116316 07/01/2016 - 06/30/2018 $265,615
Noor A Nassef Diffuse Intrinsic Pontine Glioma Joshua's Wish 07/01/2016 - 06/30/2018 $5,000
Lisa Marie Privette Vinnedge, PhD Exploring the Role of the Oncogene Dek as a Novel Player in Alzheimer’s Disease Life Sciences Research Foundation (University of Cincinnati) life2016 09/01/2016 - 08/31/2018 $8,032
Maureen O'Brien, MD T2012-002: A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo®) in Combination with UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults with Relapse of Acute Lymphoblastic Leukemia Children's Hospital Los Angeles T2012002 09/01/2016 - 08/31/2020 $10,843
Rachid Drissi, PhD Induced Telomere Damage to Treat Poor-Prognosis Pediatric Brain Tumors University of Cincinnati Drissi, Rachid, UC 07/01/2016 - 06/30/2018 $25,000
James Geller, MD COG NCTN Network Group Operations Center National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 03/01/2016 - 02/28/2019 $15,000
Adrienne Hammill, MD Lymphatic Anomalies Registry Children's Hospital Boston hammill, andrienne, 10/01/2016 - 09/30/2018 $20,000
Maureen O'Brien, MD Study Chair: NIH Clinical Trials Network (NCTN) National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 03/01/2016 - 02/28/2019 $23,366
Rajaram Nagarajan, MD Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer ALTE1621 National Institutes of Health (Children's Hospital of Philadelphia) R01 CA196854 07/01/2016 - 06/30/2020 $16,200
Maryam Fouladi, MD Scientific Leadership NCTN grant National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 09/01/2016 - 02/28/2021 $27,876
Maryam Fouladi, MD Central Nervous System Tumor Committee National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 07/01/2016 - 03/31/2017 $52,500
John P Perentesis, MD NCTN Adolescent Young Adult Committee National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 07/01/2016 - 02/28/2017 $7,501
James Geller, MD NCTN Committee Leadership National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 07/01/2016 - 02/28/2017 $7,501
Maryam Fouladi, MD Brain Tumor Center - Radio Genomics Curing Kids Cancer CKC2016 01/01/2017 - 12/31/2017 $60,000
John P Perentesis, MD A Phase I/II Trial of Ganetespib in combination with the mTOR Inhibitor Sirolimus for Patients with Unresctable or Metastatic Malignant Peripheral Nerve Sheath Tumors Sarcoma Alliance for Res through Collabo Perentesis, John, SA 03/01/2017 - 02/29/2020 $25,001
John P Perentesis, MD EveryChild (APEC14B1) Children's Oncology Group (Children's Hospital of Philadelphia) APEC14B1 10/26/2015 - 10/25/2019 $15,000
Peter Matthew Kennedy de Blank, MD Radiographic Biomarkers for Residual Disease in Pediatric Brain Tumors St. Baldrick's Foundation 318690 02/01/2017 - 06/30/2017 $57,460
Total Annual Grant Award Dollars $2,428,147

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Brian Keith Turpin, DO Amgen, Inc. $174,524
Brian Keith Turpin, DO Loxo Oncology $118,371
Christine L Phillips, MD Kite Pharma, Inc. $179,754
James Geller, MD Merck & Company, Inc. (Children's Hospital of Philadelphia) $6,500
James Geller, MD Otonomy, Inc. $75,834
John P Perentesis, MD American Family Life Assurance Company (Children's Hospital of Philadelphia) $5,878
Joseph Pressey, MD Merrimack Pharmaceuticals, Inc (Univ of Texas Hlth Science Ctr-Lubbock) $17,500
Mariko DeWire-Schottmiller, MD Tocagen $132,181
Maureen O'Brien, MD Amgen, Inc. $33,273
Maureen O'Brien, MD Bayer HealthCare Pharmaceuticals, Inc. (Children's Hospital of Philadelphia) $13,000
Maureen O'Brien, MD Incyte, Inc. (Children's Hospital of Philadelphia) $45,000
Rachid Drissi, PhD Gilead Sciences, Inc. $49,839
Total Annual Industry Award Dollars $851,654